Suboxone.com - Resources

The requested information is provided in Portable Document Format (PDF). To view and print this document you'll need to install a copy of the free Adobe® Acrobat® Reader®. If you already have Adobe Acrobat Reader installed click "View PDF" below. If you need the Acrobat Reader you can download it from the Adobe Acrobat Reader Download page.

You are leaving Suboxone.com. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Clicking on "Continue" will take you to a website that is outside the control of Reckitt Benckiser Pharmaceuticals. You are solely responsible for your interactions with such websites.

Links are provided as a public service and for informational purposes only.

You are leaving Suboxone.com and are being redirected to HereToHelpProgram.com, the website that contains the information you requested. HereToHelpProgram.com and Suboxone.com are owned and operated by Reckitt Benckiser Pharmaceuticals Inc.

As always, your information will not be sold or shared with anyone. See our privacy policy for more information.

IMPORTANT INFORMATION:

On December 8, 2006, Federal legislation was passed allowing physicians to treat up to 100 opioid-dependent patients with Suboxone at any given time—a significant increase from the previous limit of 30 patients.

There may be doctors in your area participating in a study to measure opioid dependence treatment outcomes. Patients who meet the eligibility requirements to participate in this study can receive up to $225 in compensation to complete surveys about their treatment.

NOTE: This study is only open to patients not currently under the care of a physician for opioid dependence and are seeking a treatment provider.

Please call 1-866-455-8876 between 9:00 AM to 7:30 PM EST to get more information.

Seeking Information for myself or loved one

Here to Help™ provides support throughout treatment. Whether you're seeking treatment information or you're already in treatment, we can provide resources that can help you make treatment a success.

HereToHelpProgram.com respects your privacy.
Read our Privacy Policy for more information.

If you can read this, then your browser cannot interpret Javascript. To take full advantage of what this website has to offer, please make sure that you have Javascript enabled in your browser preferences, or update to a browser that supports Javascript. Thank you.

News Room -- Safety Information -- Site Map -- En Español

Ready for Treatment?

See what treatment is like: Watch the video

Find a doctor near you who is certified to treat
opioid dependence

Get FREE support from Here to Help and talk with a live Care Coach
Join today

Could Treatment Help You?

Watch real stories from people who've worked to turn their lives around

Get FREE support from Here to Help and talk with a live Care Coach
Join today

Hear what doctors are saying about Suboxone® and Hear to Help®. Watch Video

Get FREE support from Here to Help and talk with a live Care Coach
Join today

CLINICAL TRIALS

For information on ongoing clinical trials within the United States.

Resources

The resources offered in this section may be useful for helping you or someone you care about receive treatment for opioid dependence.

Whether your first concern is how to find a doctor, how to talk to others about opioid dependence or even if dependence is likely, the information available here can help.

In addition to the information available on SUBOXONE.com, the following websites may also be of assistance:

Join Together leads initiatives to help communities respond to the harms caused by excessive alcohol and drug use and provides free internet services supporting their efforts. Learn about Join Together's current web-based services and other programs. www.jointogether.org

The Partnership for a Drug-Free America is a nonprofit coalition of communication, health, medical and educational professionals working to reduce illicit drug use and help people live healthy, drug-free lives. www.drugfree.org

Learn about Reckitt Benckiser support of Drug-Free America and download a patient brochure. www.drugfree.org/safeguard

The Center for Substance Abuse Treatment (CSAT) offers additional information on buprenorphine including information in Spanish. http://buprenorphine.samhsa.gov/

The National Alliance of Advocates for Buprenorphine Treatment (NAABT) is a site designed to educate the public about the disease of opioid dependence and the buprenorphine treatment option. www.naabt.org

Physician Clinical Support System (PCSS) was created to assist physicians in incorporating into their practices the treatment of prescription opioid and heroin dependent patients using buprenorphine. http://pcssmentor.org/

The Medical Assisted Treatment site is to raise awareness and understanding of substance abuse, the problems it creates, and the ways to deal with these problems. www.medicalassistedtreatment.org

Suboxone Assisted Treatment, a subsidiary of Medical Assisted Treatment of America caters mainly to the present and future medication—assisted treatment patients, family members, friends and other medical personnel that may need information and assistance. www.SuboxoneAssistedTreatment.org

Home -- About SUBOXONE -- Here to Help -- Real Life Stories -- What Is Opioid Dependence? -- Resources -- News Room -- Physician Locator

Glossary -- Contact Us -- Safety Information -- Prescribing Information -- Legal Statement -- Privacy Policy -- Site Map -- En Español

SUBOXONE^®, SUBUTEX^®, and Here to Help^® are registered trademarks of Reckitt Benckiser Healthcare (UK) Ltd.

Important Safety Information

SUBOXONE^® (buprenorphine HCl/naloxone HCl dihydrate sublingual tablets) (CIII) is indicated for the treatment of opioid dependence.

It is extremely dangerous to self-administer non-prescribed benzodiazepines or other depressants while taking SUBOXONE. A serious overdose and death may occur if benzodiazepines, sedatives, tranquilizers, antidepressants, or alcohol are taken at the same time as SUBOXONE.

SUBOXONE has potential for abuse and produces dependence of the opioid type, with a milder withdrawal syndrome than full agonists.

Cytolytic hepatitis and hepatitis with jaundice have been observed in the addicted population receiving buprenorphine.

Allergic reactions including bronchospasm, angioneurotic edema, and anaphylactic shock have been reported in patients taking buprenorphine.

There are no adequate and well-controlled studies of SUBOXONE (a Category C medication) in pregnancy.

Caution should be exercised when driving cars or operating machinery.

Always store buprenorphine-containing medications safely and out of the reach and sight of children. Destroy any unused medication appropriately.

The most commonly reported adverse events with SUBOXONE include: headache (36%, placebo 22%), withdrawal syndrome (25%, placebo 37%), pain (22%, placebo 19%), insomnia (14%, placebo 16%), nausea (15%, placebo 11%), and sweating (14%, placebo 10%). Please see full Prescribing Information for a complete list.

To report an adverse event caused by taking SUBOXONE, please call 1-877-782-6966. You are also encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see full Product Information